Histopathologic risk factors for progression of atypical meningioma: a retrospective cohort study evaluating the impact and clinical value of mitotic count and Ki-67
Open Access
- 1 December 2025
- journal article
- research article
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 303
Abstract
Purpose: Given the heterogeneity of atypical meningioma (AM) and potential interobserver variability in WHO grade assignment among pathologists, there is a need for more objective criteria to improve risk stratification. This study examined conventional and novel risk factors for AM progression, focusing on mitotic count (MC) and Ki-67, and explored their clinical relevance. Methods: This retrospective cohort study included 240 consecutive patients with AM surgically treated at a single tertiary institution between 2001 and 2020. The cut-off values for MC and Ki-67 were determined using the Youden index. Risk factors for progression were analyzed using cause-specific Cox proportional hazards models. Progression-free survival (PFS) was estimated using cumulative incidence function (CIF) and compared using the Gray’s test. Results: AM progression occurred in 32.5% of patients with a median time to progression of 25.2 months. The median follow-up was 42.3 months. While a clinically meaningful Ki-67 cut-off was not identified, MC ≥ 6 was significantly associated with AM progression. On multivariate analysis, age, gross total resection (GTR), MC ≥ 6, brain invasion, sheeting, and adjuvant radiotherapy (RTx) were associated with progression. RTx improved PFS in the subtotal resection (STR) group but not in the GTR group. Among GTR patients, those with MC ≥ 6 had worse outcomes. Conclusion: GTR and RTx may reduce the progression of AM. MC ≥ 6 significantly increases the risk of progression, even in GTR patients. RTx should be considered for all STR patients A more vigilant follow-up or consideration of RTx is warranted in GTR patients when a high MC is identified.Keywords
Funding Information
- Seoul National University
This publication has 60 references indexed in Scilit:
- Intracranial meningiomas of atypical (WHO grade II) histologyJournal of Neuro-Oncology, 2010
- Recurrence and regrowth of benign meningiomasBrain Tumor Pathology, 2009
- WHO grade II and III meningiomas: a study of prognostic factorsJournal of Neuro-Oncology, 2009
- LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATIONNeurosurgery, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119 Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer NetworkInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Prognostic Significance of the Mitotic Index Using the Mitosis Marker Anti–Phosphohistone H3 in MeningiomasAmerican Journal of Clinical Pathology, 2007
- Local control and overall survival in atypical meningioma: a retrospective studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Meningioma GradingAmerican Journal of Surgical Pathology, 1997
- THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENTJournal of Neurology, Neurosurgery & Psychiatry, 1957